The role of CD4-Lck in T-cell receptor antagonism: evidence for negative signaling.
AUTOR(ES)
Racioppi, L
RESUMO
Small changes in the complex between a peptide and a molecule of the major histocompatibility complex generate ligands able to partially activate (partial agonist) or even inhibit (antagonist) T-cell functions. T-cell receptor engagement of antagonist complex results in a partial zeta chain phosphorylation without activation of the associated ZAP-70 kinase. Herein we show that, despite a strong inhibition of both inositol phospholipid hydrolysis and extracellular increasing antagonist concentrations increased the activity of the CD4-Lck kinase. Addition of anti-CD4 antibody to culture medium prevented inhibitory effects induced by antagonist ligand. We propose that CD4-Lck activation triggered by antagonist complexes may act in a dominant negative mode, thus overriding stimulatory signals coming from agonist ligand. These findings identify a new T-cell signaling profile that may explain the ability of some T-cell receptor variant ligands to inhibit specific biological activities or trigger alternative activation programs.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=38389Documentos Relacionados
- The inositol 1,4,5-trisphosphate receptor is essential for T-cell receptor signaling.
- CD22-mediated stimulation of T cells regulates T-cell receptor/CD3-induced signaling.
- CD45 tyrosine phosphatase activity and membrane anchoring are required for T-cell antigen receptor signaling.
- Structure of the T-cell antigen receptor: evidence for two CD3 epsilon subunits in the T-cell receptor-CD3 complex.
- Coaggregation of the T-cell receptor with CD4 and other T-cell surface molecules enhances T-cell activation.